Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea B Apolo

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Research and Reports in Urology|April 28, 2021
Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the LiteratureRagheed Saoud, Thomas H Sanford, Stephen M Hewitt, et al.
Clinical Genitourinary Cancer|April 12, 2015
Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial CarcinomaMetin Kurtoglu, Nicole N Davarpanah, Rui Qin, et al.
Urologic Oncology|November 23, 2020
Systemic therapy in bladder preservationDaniel M Girardi, Pooja Ghatalia, Parminder Singh, et al.
Current Opinion in Oncology|April 1, 2026
Upper tract urothelial carcinoma associated with Lynch syndromeR Chelluri, S Kovell, F Montanaro, et al.
Current Opinion in Urology|September 16, 2015
Immunotherapies for bladder cancer: a new hopeFarhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, et al.
The Journal of Urology|November 9, 2017
Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial CarcinomaArlene O Siefker-Radtke, Andrea B Apolo, Trinity J Bivalacqua, et al.
Journal of the American Academy of Dermatology|May 17, 2014
Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppressionDominique C Pichard, Jennifer R Hensley, Esther Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancerAndrea B Apolo, Jamie Riches, Heiko Schöder, et al.
Journal for Immunotherapy of Cancer|March 1, 2022
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survivalJuliane Manitz, Sandra P D'Angelo, Andrea B Apolo, et al.
Therapeutic Advances in Medical Oncology|July 18, 2022
Cabozantinib for the treatment of solid tumors: a systematic reviewPablo Maroto, Camillo Porta, Jaume Capdevila, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Research and Reports in Urology|April 28, 2021
Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the LiteratureRagheed Saoud, Thomas H Sanford, Stephen M Hewitt, et al.
Clinical Genitourinary Cancer|April 12, 2015
Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial CarcinomaMetin Kurtoglu, Nicole N Davarpanah, Rui Qin, et al.
Urologic Oncology|November 23, 2020
Systemic therapy in bladder preservationDaniel M Girardi, Pooja Ghatalia, Parminder Singh, et al.
Current Opinion in Oncology|April 1, 2026
Upper tract urothelial carcinoma associated with Lynch syndromeR Chelluri, S Kovell, F Montanaro, et al.
Current Opinion in Urology|September 16, 2015
Immunotherapies for bladder cancer: a new hopeFarhad Fakhrejahani, Yusuke Tomita, Agnes Maj-Hes, et al.
The Journal of Urology|November 9, 2017
Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial CarcinomaArlene O Siefker-Radtke, Andrea B Apolo, Trinity J Bivalacqua, et al.
Journal of the American Academy of Dermatology|May 17, 2014
Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppressionDominique C Pichard, Jennifer R Hensley, Esther Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancerAndrea B Apolo, Jamie Riches, Heiko Schöder, et al.
Journal for Immunotherapy of Cancer|March 1, 2022
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survivalJuliane Manitz, Sandra P D'Angelo, Andrea B Apolo, et al.
Therapeutic Advances in Medical Oncology|July 18, 2022
Cabozantinib for the treatment of solid tumors: a systematic reviewPablo Maroto, Camillo Porta, Jaume Capdevila, et al.
Pageof 12